NLRP3 and cardiovascular disorder: The balance of opinion is predominantly in favor of the detrimental effect that the NLRP3 inflammasome contributes to the pathological process of cardiovascular disease and acknowledges that the NLRP3 inflammasome is a promising therapeutic target [19, 20].